top of page

NICE recommends three type 2 diabetes treatments

The National Institute for Health and Care Excellence (NICE) has published final guidance recommending three drugs for treating type 2 diabetes: Janssen’s Invokana (canagliflozin), AstraZeneca’s Forxiga (dapagliflozin) and Boehringer Ingelheim’s Jardiance (empagliflozin).

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page